Literature DB >> 15527776

Signal transduction mechanism of the seabream growth hormone secretagogue receptor.

Chi-Bun Chan1, Po-Ki Leung, Helen Wise, Christopher H K Cheng.   

Abstract

We have recently cloned the full-length cDNAs of the two growth hormone secretagogue receptor (GHSR) subtypes from a teleost species, the black seabream (Acanthopagrus schlegeli) [Mol. Cell. Endocrinol. 214 (2004) 81], namely sbGHSR-1a and sbGHSR-1b. Functional expression of these two receptor constructs in human embryonic kidney 293 (HEK293) cells indicated that stimulation of sbGHSR-1a by growth hormone secretagogues (GHS) could evoke increases in intracellular Ca2+ concentration ([Ca2+]i), whereas sbGHSR-1b appeared to play an inhibitory role on the signal transduction activity of sbGHSR-1a. In the present study, we have further investigated the signal transduction mechanism of sbGHSR-1a. The peptide GHS GHRP-6 and the non-peptide GHS L163,540 were able to trigger a receptor specific and phospholipase C (PLC)-dependent elevation of [Ca2+]i in HEK293 cells stably expressing sbGHSR-1a. This GHS-induced calcium mobilization was also dependent on protein kinase C activated L-type calcium channel opening. It was found that sbGHSR-1a could function in an agonist-independent manner as it exhibited a high basal activity of inositol phosphate production in the absence of GHS, indicating that the fish receptor is constitutively active. In addition, the extracellular signal-regulated kinases 1 and 2 (ERK1/2) were found to be activated upon stimulation of sbGHSR-1a by GHRP-6. This observation provides direct evidence in the coupling of sbGHSR-1a to ERK1/2 activation. Neither Gs nor Gi proteins are coupled to the receptor, as GHS did not induce cAMP production nor inhibit forskolin-stimulated cAMP accumulation in the sbGHSR-1a bearing cells. Furthermore, the ability of the GHSR antagonist D-Lys3-GHRP-6 to inhibit basal PLC and basal ERK1/2 activity suggests that this compound is an inverse agonist. In summary, the sbGHSR-1a appears to couple through the G(q/11)-mediated pathway to activate PLC, resulting in increased IP3 production and Ca2+ mobilization from both intracellular and extracellular stores. Moreover, sbGHSR-1a may trigger multiple signal transduction cascades to exert its physiological functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15527776     DOI: 10.1016/j.febslet.2004.08.088

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

Review 1.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

2.  Ghrelin receptors in non-Mammalian vertebrates.

Authors:  Hiroyuki Kaiya; Kenji Kangawa; Mikiya Miyazato
Journal:  Front Endocrinol (Lausanne)       Date:  2013-07-17       Impact factor: 5.555

Review 3.  Therapeutic Potential of Targeting the Ghrelin Pathway.

Authors:  Gustav Colldén; Matthias H Tschöp; Timo D Müller
Journal:  Int J Mol Sci       Date:  2017-04-11       Impact factor: 5.923

Review 4.  A Comparative Update on the Neuroendocrine Regulation of Growth Hormone in Vertebrates.

Authors:  Emilio J Vélez; Suraj Unniappan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-23       Impact factor: 5.555

5.  Metabolic insights from a GHSR-A203E mutant mouse model.

Authors:  Lola J Torz; Sherri Osborne-Lawrence; Juan Rodriguez; Zhenyan He; María Paula Cornejo; Emilio Román Mustafá; Chunyu Jin; Natalia Petersen; Morten A Hedegaard; Maja Nybo; Valentina Martínez Damonte; Nathan P Metzger; Bharath K Mani; Kevin W Williams; Jesica Raingo; Mario Perello; Birgitte Holst; Jeffrey M Zigman
Journal:  Mol Metab       Date:  2020-04-24       Impact factor: 7.422

Review 6.  New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides.

Authors:  Ewa Mlyczyńska; Marta Kieżun; Patrycja Kurowska; Monika Dawid; Karolina Pich; Natalia Respekta; Mathilde Daudon; Edyta Rytelewska; Kamil Dobrzyń; Barbara Kamińska; Tadeusz Kamiński; Nina Smolińska; Joelle Dupont; Agnieszka Rak
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.